Decreased Tissue Inhibitor of Metalloproteinase-2/Matrix Metalloproteinase Ratio in the Acute Phase of Aortic Dissection

Surgery Today

Volumn 34, Issue 3, 2004, Pages 220-225

  Manabe, Takahiro ^a,b   Imoto, Kiyotaka ^a   Uchida, Keiji ^a   Doi, Chiharu ^a   Takanashi, Yoshinori ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NONE   (Germany)

Author keywords

Aortic dissection; Matrix metalloproteinase 2; Matrix metalloproteinase 9; TIMP MMP ratio; Tissue inhibitor of metalloproteinase 2

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ABDOMINAL AORTA ANEURYSM; ACUTE DISEASE; ADULT; AGED; AORTA DISSECTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MECHANISM; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; QUANTITATIVE ANALYSIS; TUNICA MEDIA; VASCULAR FRAGILITY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 1542315273     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-003-2683-3     Document Type: Article

References (28)

1. Sinatra R, Melina G, Pulitani I, Fiorani B, Ruvolo G, Marino B. Emergency operation for acute type A aortic dissection: neurologic complications and early mortality. Ann Thorac Surg 2001;71:33-8.
2. Yamashita C, Okada M, Ataka K, Yoshida M, Yoshimura N, Azami T, et al. Open distal anastomosis in retrograde cerebral perfusion for repair of ascending aortic dissection. Ann Thorac Surg 1997;64:665-9.
3. Pretre R, Segesser LK. Aortic dissection. Lancet 1997;349:1461-4.
4. Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol 1984;53:849-55.
5. Roberts WC. Aortic dissection: anatomy, consequences and causes. Am Heart J 1981;101:195-214.
6. Fradet G, Jamieson WR, Janusz MT, Munro AI, Ling H, Miyagishita RT, et al. Aortic dissection. A six year experience with 117 patients. Am J Surg 1988;155:697-700.
7. Nakashima Y, Kurozumi T, Sueishi K, Tanaka K. Dissecting aneurysm: a clinicopathologic and histopathologic study of 111 autopsied cases. Hum Pathol 1990;21:291-6.
8. Whittle MA, Robins SP, Hasleton PS, Anderson JC. Biochemical investigation of possible lesions in human aorta that predispose to dissecting aneurysm: pyridinoline crosslinks. Cardiovasc Res 1987;21:161-8.
9. Derouette S, Hornebeck W, Loisance D, Godeau G, Cachera JP, Robert L. Studies on elastic tissue of aorta in aortic dissections and Marfan syndrome. Pathol Biol 1981;29:539-47.
10. Ishii T, Asuwa N. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. Hum Pathol 2000;31:640-6.
11. Emonard H, Grimaud JA. Matrix metalloproteinases: a review. Cell Moll Biol 1990;36:136-53.
12. Lijnen HR, Collen D. Matrix metalloproteinase system deficiencies and matrix degradation. Thromb Haemost 1999;82:837-45.
13. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterior Thromb Vasc Biol 1995;15:1145-51.
14. Grange JJ, Davis V, Baxter BT. Pathogenesis of abdominal aortic aneurysm: an update and look toward the future. Cardiovasc Surg 1997;5:256-65.
15. McMillan WD, Tamarina NA, Cipollone M, Johnson DA, Parker MA, Pearce WH. Size matters: The relationship between MMP-9 expression and aortic diameter. Circulation 1997;96:2228-32.
16. Schneiderman J, Bordin GM, Adar R, Smolinsky A, Seiffert D, Engelberg I, et al. Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms. Am J Pathol 1998;152:703-10.
17. Werb Z, Chin JR. Extracellular matrix remodeling during morphogenesis. Ann NY Acad Sci 1998;23:110-8.
18. Johnson LL, Dyer R, Hupe DJ. Matrix metalloproteinases. Curr Opin Chem Biol 1998;2:466-71.
19. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72-and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991;266:13070-5.
20. Roberts WC, Honig HS. The spectrum of cardiovascular disease in the Marfan syndrome: a clinico-morphologic study of 18 necropsy patients and comparison to 151 previously reported necropsy patients. Am Heart J 1982;104:115-35.
21. Lee B, Godfrey M, Vitale E, Hori H, Mattei MG, Sarfarazi M, et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 1991;352:330-4.
22. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991;352:337-9.
23. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
24. Soo C, Shaw WW, Zhang X, Longaker MT, Howard EW, Ting K. Differential expression of matrix metalloproteinase and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg 2000;105:638-47.
25. Newman KM, Jean-Claude J, Li H, Scholes JV, Ogata Y, Nagase H, et al. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 1994;20:814-20.
26. Tompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 1995;96:318-26.
27. Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol 1997;137:67-77.
28. McMillan WD, Patteson BK, Keen RR, Pearce WH. In situ localization and quantification of seventy-two kilodalton type IV collagenase in aneurysmal, occulusive, and normal aorta. J Vasc Surg 1995;22:295-305.